1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Currently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	expect	_	_	VBP	_	_	_	_	_
5	foods	_	_	NNS	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	satisfy	_	_	VB	_	_	_	_	_
8	hunger	_	_	NN	_	_	_	_	_
9	while	_	_	IN	_	_	_	_	_
10	delivering	_	_	VBG	_	_	_	_	_
11	nutrients	_	_	NNS	_	_	_	_	_
12	essential	_	_	JJ	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	humans	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	but	_	_	CC	_	_	_	_	_
17	their	_	_	PRP$	_	_	_	_	_
18	task	_	_	NN	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	also	_	_	RB	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	prevention	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	diet-related	_	_	JJ	_	_	_	_	_
25	diseases	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Functional	_	_	JJ	_	_	_	_	_
2	foods	_	_	NNS	_	_	_	_	_
3	play	_	_	VBP	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	significant	_	_	JJ	_	_	_	_	_
6	role	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	this	_	_	DT	_	_	_	_	_
9	case	_	_	NN	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	Due	_	_	JJ	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	their	_	_	PRP$	_	_	_	_	_
4	beneficial	_	_	JJ	_	_	_	_	_
5	physiological	_	_	JJ	_	_	_	_	_
6	effects	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	including	_	_	VBG	_	_	_	_	_
9	antioxidant	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	anticancer	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	anti-inflammatory	_	_	JJ	_	_	_	_	_
15	properties	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	nutrients	_	_	NNS	_	_	_	_	_
18	from	_	_	IN	_	_	_	_	_
19	marine	_	_	JJ	_	_	_	_	_
20	animals	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	as	_	_	RB	_	_	_	_	_
23	well	_	_	RB	_	_	_	_	_
24	as	_	_	IN	_	_	_	_	_
25	bioactive	_	_	JJ	_	_	_	_	_
26	components	_	_	NNS	_	_	_	_	_
27	have	_	_	VBP	_	_	_	_	_
28	great	_	_	JJ	_	_	_	_	_
29	potential	_	_	NN	_	_	_	_	_
30	as	_	_	IN	_	_	_	_	_
31	ingredients	_	_	NNS	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	functional	_	_	JJ	_	_	_	_	_
34	foods	_	_	NNS	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	After	_	_	IN	_	_	_	_	_
2	filleting	_	_	VBG	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	fish	_	_	NN	_	_	_	_	_
5	processing	_	_	NN	_	_	_	_	_
6	waste	_	_	NN	_	_	_	_	_
7	comprises	_	_	VBZ	_	_	_	_	_
8	75	_	_	CD	_	_	_	_	_
9	%	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	overall	_	_	JJ	_	_	_	_	_
13	fish	_	_	NN	_	_	_	_	_
14	weight	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Approximately	_	_	RB	_	_	_	_	_
2	30	_	_	CD	_	_	_	_	_
3	%	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	waste	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	form	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	bones	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	skins	_	_	NNS	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Gelatine	_	_	NN	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	derived	_	_	VBN	_	_	_	_	_
5	from	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	processing	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	fish	_	_	NN	_	_	_	_	_
10	skins	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	solving	_	_	VBG	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	problem	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	waste	_	_	NN	_	_	_	_	_
17	disposal	_	_	NN	_	_	_	_	_
18	while	_	_	IN	_	_	_	_	_
19	producing	_	_	VBG	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	value-added	_	_	JJ	_	_	_	_	_
22	product	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Its	_	_	PRP$	_	_	_	_	_
2	fast	_	_	JJ	_	_	_	_	_
3	growth	_	_	NN	_	_	_	_	_
4	rate	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	as	_	_	RB	_	_	_	_	_
7	well	_	_	RB	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	good	_	_	JJ	_	_	_	_	_
10	fodder	_	_	NN	_	_	_	_	_
11	usage	_	_	NN	_	_	_	_	_
12	cause	_	_	VBP	_	_	_	_	_
13	carp	_	_	NN	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	Cyprinus	_	_	NNP	_	_	_	_	_
16	carpio	_	_	NN	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	be	_	_	VB	_	_	_	_	_
20	one	_	_	CD	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	most	_	_	RBS	_	_	_	_	_
24	commonly-bred	_	_	JJ	_	_	_	_	_
25	species	_	_	NNS	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	eastern	_	_	JJ	_	_	_	_	_
28	Europe	_	_	NNP	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	as	_	_	RB	_	_	_	_	_
31	well	_	_	RB	_	_	_	_	_
32	as	_	_	IN	_	_	_	_	_
33	in	_	_	IN	_	_	_	_	_
34	Poland	_	_	NNP	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	annual	_	_	JJ	_	_	_	_	_
3	European	_	_	JJ	_	_	_	_	_
4	carp	_	_	NN	_	_	_	_	_
5	production	_	_	NN	_	_	_	_	_
6	totals	_	_	VBZ	_	_	_	_	_
7	approximately	_	_	RB	_	_	_	_	_
8	4,328,083	_	_	CD	_	_	_	_	_
9	tons	_	_	NNS	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	our	_	_	PRP$	_	_	_	_	_
3	previous	_	_	JJ	_	_	_	_	_
4	research	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	we	_	_	PRP	_	_	_	_	_
7	demonstrated	_	_	VBD	_	_	_	_	_
8	that	_	_	IN	_	_	_	_	_
9	protein	_	_	NN	_	_	_	_	_
10	hydrolysates	_	_	NNS	_	_	_	_	_
11	from	_	_	IN	_	_	_	_	_
12	carp	_	_	NN	_	_	_	_	_
13	skin	_	_	NN	_	_	_	_	_
14	gelatine	_	_	NN	_	_	_	_	_
15	hydrolysate	_	_	NN	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	CSGH	_	_	NN	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	can	_	_	MD	_	_	_	_	_
20	be	_	_	VB	_	_	_	_	_
21	potential	_	_	JJ	_	_	_	_	_
22	bioactive	_	_	JJ	_	_	_	_	_
23	peptide	_	_	NN	_	_	_	_	_
24	sources	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Bioactive	_	_	JJ	_	_	_	_	_
2	peptides	_	_	NNS	_	_	_	_	_
3	consisting	_	_	VBG	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	2	_	_	CD	_	_	_	_	_
6	–	_	_	TO	_	_	_	_	_
7	20	_	_	CD	_	_	_	_	_
8	residues	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	amino	_	_	NN	_	_	_	_	_
11	acids	_	_	NNS	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	inactive	_	_	JJ	_	_	_	_	_
14	within	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	sequences	_	_	NNS	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	parent	_	_	NN	_	_	_	_	_
19	proteins	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	released	_	_	VBN	_	_	_	_	_
5	via	_	_	IN	_	_	_	_	_
6	enzymatic	_	_	JJ	_	_	_	_	_
7	hydrolysis	_	_	NN	_	_	_	_	_
8	either	_	_	CC	_	_	_	_	_
9	at	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	time	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	digestion	_	_	NN	_	_	_	_	_
14	or	_	_	CC	_	_	_	_	_
15	during	_	_	IN	_	_	_	_	_
16	food	_	_	NN	_	_	_	_	_
17	processing	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Antioxidant	_	_	JJ	_	_	_	_	_
2	peptides	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	among	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	most	_	_	RBS	_	_	_	_	_
7	frequently-studied	_	_	JJ	_	_	_	_	_
8	bioactive	_	_	JJ	_	_	_	_	_
9	peptides	_	_	NNS	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	particular	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	health	_	_	NN	_	_	_	_	_
7	food	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	pharmaceutical	_	_	JJ	_	_	_	_	_
10	industry	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	fish	_	_	NN	_	_	_	_	_
13	protein	_	_	NN	_	_	_	_	_
14	hydrolysates	_	_	NNS	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	antioxidant	_	_	JJ	_	_	_	_	_
17	properties	_	_	NNS	_	_	_	_	_
18	have	_	_	VBP	_	_	_	_	_
19	become	_	_	VBN	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	highly	_	_	RB	_	_	_	_	_
22	interesting	_	_	JJ	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	discussed	_	_	VBN	_	_	_	_	_
25	subject	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	reduction	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	bioactive	_	_	JJ	_	_	_	_	_
8	peptide	_	_	NN	_	_	_	_	_
9	activity	_	_	NN	_	_	_	_	_
10	due	_	_	JJ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	susceptibility	_	_	NN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	proteolytic	_	_	JJ	_	_	_	_	_
15	degradation	_	_	NN	_	_	_	_	_
16	or	_	_	CC	_	_	_	_	_
17	undesirable	_	_	JJ	_	_	_	_	_
18	interactions	_	_	NNS	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	other	_	_	JJ	_	_	_	_	_
21	compounds	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Encapsulation	_	_	NN	_	_	_	_	_
2	usage	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	highly	_	_	RB	_	_	_	_	_
6	significant	_	_	JJ	_	_	_	_	_
7	factor	_	_	NN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	protection	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	these	_	_	DT	_	_	_	_	_
13	biomolecules	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	consequently	_	_	RB	_	_	_	_	_
16	providing	_	_	VBG	_	_	_	_	_
17	greater	_	_	JJR	_	_	_	_	_
18	therapeutic	_	_	JJ	_	_	_	_	_
19	efficacy	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Encapsulation	_	_	NN	_	_	_	_	_
2	may	_	_	MD	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	permit	_	_	VB	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	development	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	delivery	_	_	NN	_	_	_	_	_
10	system	_	_	NN	_	_	_	_	_
11	through	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	improvement	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	stability	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	causing	_	_	VBG	_	_	_	_	_
18	an	_	_	DT	_	_	_	_	_
19	increase	_	_	NN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	residence	_	_	NN	_	_	_	_	_
22	time	_	_	NN	_	_	_	_	_
23	regarding	_	_	VBG	_	_	_	_	_
24	circulation	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	while	_	_	IN	_	_	_	_	_
27	at	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	same	_	_	JJ	_	_	_	_	_
30	time	_	_	NN	_	_	_	_	_
31	causing	_	_	VBG	_	_	_	_	_
32	a	_	_	DT	_	_	_	_	_
33	significant	_	_	JJ	_	_	_	_	_
34	decrease	_	_	NN	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	toxicity	_	_	NN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	encapsulation	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	bioactive	_	_	JJ	_	_	_	_	_
5	ingredients	_	_	NNS	_	_	_	_	_
6	within	_	_	IN	_	_	_	_	_
7	colloidal	_	_	JJ	_	_	_	_	_
8	particles	_	_	NNS	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	an	_	_	DT	_	_	_	_	_
11	influential	_	_	JJ	_	_	_	_	_
12	means	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	protecting	_	_	VBG	_	_	_	_	_
15	them	_	_	PRP	_	_	_	_	_
16	from	_	_	IN	_	_	_	_	_
17	degradation	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Different	_	_	JJ	_	_	_	_	_
2	types	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	colloidal	_	_	JJ	_	_	_	_	_
5	delivery	_	_	NN	_	_	_	_	_
6	systems	_	_	NNS	_	_	_	_	_
7	have	_	_	VBP	_	_	_	_	_
8	been	_	_	VBN	_	_	_	_	_
9	developed	_	_	VBN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	example	_	_	NN	_	_	_	_	_
13	emulsions	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	nanoemulsions	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	microemulsions	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	liposomes	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	solid	_	_	JJ	_	_	_	_	_
22	lipid	_	_	NN	_	_	_	_	_
23	nanoparticles	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	hydrogel	_	_	NN	_	_	_	_	_
26	beads	_	_	NNS	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	biopolymer	_	_	NN	_	_	_	_	_
30	nanoparticles	_	_	NNS	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	each	_	_	DT	_	_	_	_	_
33	with	_	_	IN	_	_	_	_	_
34	its	_	_	PRP$	_	_	_	_	_
35	own	_	_	JJ	_	_	_	_	_
36	advantages	_	_	NNS	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	disadvantages	_	_	NNS	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Edible	_	_	JJ	_	_	_	_	_
2	coating	_	_	NN	_	_	_	_	_
3	materials	_	_	NNS	_	_	_	_	_
4	are	_	_	VBP	_	_	_	_	_
5	usually	_	_	RB	_	_	_	_	_
6	composed	_	_	VBN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	polysaccharides	_	_	NNS	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	proteins	_	_	NNS	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	materials	_	_	NNS	_	_	_	_	_
3	could	_	_	MD	_	_	_	_	_
4	be	_	_	VB	_	_	_	_	_
5	used	_	_	VBN	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	only	_	_	RB	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	form	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	capsules	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	but	_	_	CC	_	_	_	_	_
15	also	_	_	RB	_	_	_	_	_
16	as	_	_	IN	_	_	_	_	_
17	films	_	_	NNS	_	_	_	_	_
18	covering	_	_	VBG	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	food	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Edible	_	_	JJ	_	_	_	_	_
2	films	_	_	NNS	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	coatings	_	_	NNS	_	_	_	_	_
5	often	_	_	RB	_	_	_	_	_
6	containing	_	_	VBG	_	_	_	_	_
7	bioactive	_	_	JJ	_	_	_	_	_
8	agents	_	_	NNS	_	_	_	_	_
9	or	_	_	CC	_	_	_	_	_
10	food	_	_	NN	_	_	_	_	_
11	additives	_	_	NNS	_	_	_	_	_
12	like	_	_	IN	_	_	_	_	_
13	nutrients	_	_	NNS	_	_	_	_	_
14	are	_	_	VBP	_	_	_	_	_
15	gaining	_	_	VBG	_	_	_	_	_
16	relevance	_	_	NN	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	potential	_	_	JJ	_	_	_	_	_
19	tools	_	_	NNS	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	reduce	_	_	VB	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	deleterious	_	_	JJ	_	_	_	_	_
24	effects	_	_	NNS	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	incidence	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	microorganisms	_	_	NNS	_	_	_	_	_
30	or	_	_	CC	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	improve	_	_	VB	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	nutritional	_	_	JJ	_	_	_	_	_
35	value	_	_	NN	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	a	_	_	DT	_	_	_	_	_
38	product	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	research	_	_	NN	_	_	_	_	_
4	by	_	_	IN	_	_	_	_	_
5	Sapper	_	_	NNP	_	_	_	_	_
6	et	_	_	FW	_	_	_	_	_
7	al.	_	_	FW	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	polysaccharide	_	_	NN	_	_	_	_	_
10	protein	_	_	NN	_	_	_	_	_
11	films	_	_	NNS	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	addition	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	thyme	_	_	NN	_	_	_	_	_
17	essential	_	_	JJ	_	_	_	_	_
18	oil	_	_	NN	_	_	_	_	_
19	were	_	_	VBD	_	_	_	_	_
20	obtained	_	_	VBN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	which	_	_	WDT	_	_	_	_	_
23	has	_	_	VBZ	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	strong	_	_	JJ	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	vitro	_	_	NN	_	_	_	_	_
28	fungicidal	_	_	JJ	_	_	_	_	_
29	effect	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	vivo	_	_	NN	_	_	_	_	_
5	studies	_	_	NNS	_	_	_	_	_
6	did	_	_	VBD	_	_	_	_	_
7	not	_	_	RB	_	_	_	_	_
8	confirm	_	_	VB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	inhibitory	_	_	JJ	_	_	_	_	_
11	effect	_	_	NN	_	_	_	_	_
12	on	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	surface	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	apples	_	_	NNS	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Furthermore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	data	_	_	NNS	_	_	_	_	_
5	from	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	literature	_	_	NN	_	_	_	_	_
8	indicate	_	_	VBP	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	properties	_	_	NNS	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	biologically-active	_	_	JJ	_	_	_	_	_
14	compounds	_	_	NNS	_	_	_	_	_
15	tested	_	_	VBN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	vitro	_	_	FW	_	_	_	_	_
18	are	_	_	VBP	_	_	_	_	_
19	not	_	_	RB	_	_	_	_	_
20	always	_	_	RB	_	_	_	_	_
21	confirmed	_	_	VBN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	vivo	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Bioactive	_	_	JJ	_	_	_	_	_
2	peptides	_	_	NNS	_	_	_	_	_
3	differ	_	_	VBP	_	_	_	_	_
4	from	_	_	IN	_	_	_	_	_
5	other	_	_	JJ	_	_	_	_	_
6	food	_	_	NN	_	_	_	_	_
7	bioactive	_	_	JJ	_	_	_	_	_
8	compounds	_	_	NNS	_	_	_	_	_
9	like	_	_	IN	_	_	_	_	_
10	vitamins	_	_	NNS	_	_	_	_	_
11	or	_	_	CC	_	_	_	_	_
12	polyphenols	_	_	NNS	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	slight	_	_	JJ	_	_	_	_	_
4	heterogeneity	_	_	NN	_	_	_	_	_
5	regarding	_	_	VBG	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	chemical	_	_	JJ	_	_	_	_	_
8	species	_	_	NNS	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	protein	_	_	NN	_	_	_	_	_
12	hydrolysates	_	_	NNS	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Most	_	_	JJS	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	on	_	_	IN	_	_	_	_	_
4	bioactive	_	_	JJ	_	_	_	_	_
5	peptides	_	_	NNS	_	_	_	_	_
6	focus	_	_	VBP	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	finding	_	_	VBG	_	_	_	_	_
9	new	_	_	JJ	_	_	_	_	_
10	bioactivity	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	protein	_	_	NN	_	_	_	_	_
13	precursors	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	while	_	_	IN	_	_	_	_	_
16	limited	_	_	JJ	_	_	_	_	_
17	attention	_	_	NN	_	_	_	_	_
18	is	_	_	VBZ	_	_	_	_	_
19	paid	_	_	VBN	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	their	_	_	PRP$	_	_	_	_	_
22	biostability	_	_	NN	_	_	_	_	_
23	or	_	_	CC	_	_	_	_	_
24	bioavailability	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Presently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	there	_	_	EX	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	gap	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	literature	_	_	NN	_	_	_	_	_
10	illustrating	_	_	VBG	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	various	_	_	JJ	_	_	_	_	_
13	aspects	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	encapsulation	_	_	NN	_	_	_	_	_
16	concerning	_	_	VBG	_	_	_	_	_
17	food-protein-derived	_	_	JJ	_	_	_	_	_
18	bioactive	_	_	JJ	_	_	_	_	_
19	peptides	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	there	_	_	EX	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	need	_	_	NN	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	vivo	_	_	NN	_	_	_	_	_
10	studies	_	_	NNS	_	_	_	_	_
11	applying	_	_	VBG	_	_	_	_	_
12	animal	_	_	NN	_	_	_	_	_
13	models	_	_	NNS	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	confirm	_	_	VB	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	success	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	encapsulation	_	_	NN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	bioactivity	_	_	NN	_	_	_	_	_
22	retention	_	_	NN	_	_	_	_	_
23	following	_	_	VBG	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	oral	_	_	JJ	_	_	_	_	_
26	consumption	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	these	_	_	DT	_	_	_	_	_
29	products	_	_	NNS	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Polysaccharides	_	_	NNS	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	generally	_	_	RB	_	_	_	_	_
4	ideal	_	_	JJ	_	_	_	_	_
5	as	_	_	IN	_	_	_	_	_
6	delivery	_	_	NN	_	_	_	_	_
7	agents	_	_	NNS	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	microcapsules	_	_	NNS	_	_	_	_	_
10	as	_	_	IN	_	_	_	_	_
11	they	_	_	PRP	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	structurally	_	_	RB	_	_	_	_	_
14	stable	_	_	JJ	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	ample	_	_	JJ	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	nature	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	inexpensive	_	_	JJ	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Polysaccharides	_	_	NNS	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	reactive	_	_	JJ	_	_	_	_	_
4	functional	_	_	JJ	_	_	_	_	_
5	groups	_	_	NNS	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	carboxyl	_	_	NN	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	COOH	_	_	NN	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	hydroxyl	_	_	NN	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	OH	_	_	UH	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	amide	_	_	NN	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	NH2	_	_	NN	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	sulphate	_	_	NN	_	_	_	_	_
25	groups	_	_	NNS	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	SO4H	_	_	NNP	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	)	_	_	-RRB-	_	_	_	_	_
30	are	_	_	VBP	_	_	_	_	_
31	good	_	_	JJ	_	_	_	_	_
32	candidates	_	_	NNS	_	_	_	_	_
33	as	_	_	IN	_	_	_	_	_
34	carrier	_	_	NN	_	_	_	_	_
35	matrices	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_
37	Furcellaran	_	_	NNP	_	_	_	_	_
38	(	_	_	-LRB-	_	_	_	_	_
39	FUR	_	_	NNP	_	_	_	_	_
40	)	_	_	-RRB-	_	_	_	_	_
41	is	_	_	VBZ	_	_	_	_	_
42	structurally	_	_	RB	_	_	_	_	_
43	connected	_	_	VBN	_	_	_	_	_
44	with	_	_	IN	_	_	_	_	_
45	the	_	_	DT	_	_	_	_	_
46	algal	_	_	NN	_	_	_	_	_
47	polysaccharide	_	_	NN	_	_	_	_	_
48	κ	_	_	NN	_	_	_	_	_
49	carrageenan	_	_	NN	_	_	_	_	_
50	;	_	_	:	_	_	_	_	_
51	however	_	_	RB	_	_	_	_	_
52	,	_	_	,	_	_	_	_	_
53	there	_	_	EX	_	_	_	_	_
54	is	_	_	VBZ	_	_	_	_	_
55	a	_	_	DT	_	_	_	_	_
56	major	_	_	JJ	_	_	_	_	_
57	structural	_	_	JJ	_	_	_	_	_
58	difference	_	_	NN	_	_	_	_	_
59	.	_	_	.	_	_	_	_	_


1	Furcellaran	_	_	NNP	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	which	_	_	WDT	_	_	_	_	_
4	has	_	_	VBZ	_	_	_	_	_
5	units	_	_	NNS	_	_	_	_	_
6	consisting	_	_	VBG	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	fragment	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	1	_	_	CD	_	_	_	_	_
13	–	_	_	TO	_	_	_	_	_
14	3	_	_	CD	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	β-D-galactopyranose	_	_	NN	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	sulphate	_	_	NN	_	_	_	_	_
20	group	_	_	NN	_	_	_	_	_
21	at	_	_	IN	_	_	_	_	_
22	C-4	_	_	NNP	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	1	_	_	CD	_	_	_	_	_
26	–	_	_	TO	_	_	_	_	_
27	4	_	_	CD	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	-3	_	_	CD	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	6-anhydro-α-D-galactopyranose	_	_	NN	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	is	_	_	VBZ	_	_	_	_	_
34	used	_	_	VBN	_	_	_	_	_
35	as	_	_	IN	_	_	_	_	_
36	a	_	_	DT	_	_	_	_	_
37	gelling	_	_	VBG	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	stabilizing	_	_	VBG	_	_	_	_	_
40	agent	_	_	NN	_	_	_	_	_
41	in	_	_	IN	_	_	_	_	_
42	the	_	_	DT	_	_	_	_	_
43	food	_	_	NN	_	_	_	_	_
44	industry	_	_	NN	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	furcellaran	_	_	NN	_	_	_	_	_
5	can	_	_	MD	_	_	_	_	_
6	form	_	_	VB	_	_	_	_	_
7	complexes	_	_	NNS	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	various	_	_	JJ	_	_	_	_	_
10	proteins	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	which	_	_	WDT	_	_	_	_	_
13	can	_	_	MD	_	_	_	_	_
14	be	_	_	VB	_	_	_	_	_
15	used	_	_	VBN	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	encapsulation	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	food	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	agriculture	_	_	NN	_	_	_	_	_
22	applications	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	interactions	_	_	NNS	_	_	_	_	_
3	between	_	_	IN	_	_	_	_	_
4	proteins	_	_	NNS	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	polysaccharides	_	_	NNS	_	_	_	_	_
7	can	_	_	MD	_	_	_	_	_
8	lead	_	_	VB	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	creation	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	completely	_	_	RB	_	_	_	_	_
14	new	_	_	JJ	_	_	_	_	_
15	materials	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Negatively-charged	_	_	JJ	_	_	_	_	_
2	furcellaran	_	_	NN	_	_	_	_	_
3	can	_	_	MD	_	_	_	_	_
4	act	_	_	VB	_	_	_	_	_
5	as	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	film-forming	_	_	JJ	_	_	_	_	_
8	matrix	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	active	_	_	JJ	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	biopolymer	_	_	JJ	_	_	_	_	_
13	films	_	_	NNS	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	as	_	_	IN	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	carrier	_	_	NN	_	_	_	_	_
18	material	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	encapsulation	_	_	NN	_	_	_	_	_
22	process	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_

